Magic Hour
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen seeking European approval of osteoporosis drug Evinity

By   /   Monday, January 8th, 2018  /   Comments Off on Amgen seeking European approval of osteoporosis drug Evinity

    Print       Email
On the heels of a new Food and Drug Administration approval for its billion-dollar drug Xgeva, Amgen announced that the European Medicines Agency would consider an application for osteoporosis drug Evinity. Evinity, developed in conjunction with Brussels-based UCB, aims to treat osteoporosis and reduce the risk of fracture in higher-risk populations, including postmenopausal women, by…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Citizens Business Bank reports ‘solid loan growth,’ higher earnings in Q3

Read More →